The programme also features a series of engaging sponsored sessions, offering valuable insights and perspectives from our partners.
On this page, you will find a complete overview of these sessions, including detailed information about the content and speakers. We invite you to explore and discover the contributions of our sponsors.
For the full scientific programme click here and view here all the sponsors for IAGG 2026.
Programme
Monday 6 July 12:30 – 13:30 hrs.
| 12:30 – 12:35 | Welcome & Introduction |
| 12:35 – 12:55 | Recognizing Alzheimer’s Disease in Clinical Practice By Prof. Dr. Majon Muller, Amsterdam UMCDiagnosing Alzheimer’s disease is challenging because its symptoms often overlap with other causes of cognitive decline and dementia. Current and emerging biomarkers for Alzheimer’s disease will enable earlier detection, which is increasingly important for identifying patients who may benefit from disease-modifying therapies. |
| 12:55 – 13:15 | Measuring Benefit, Choosing Wisely: A Geriatric Perspective on Alzheimer’s Therapies Prof. Dr. Jos Tournoy, UZ LeuvenTreatment effects can be viewed through multiple lenses, including group-level differences and slowing of disease progression, each shaping how benefit is perceived. Applying these insights to older adults requires individualized assessment of frailty, comorbidity, and goals of care to ensure appropriate and meaningful use. |
| 13:15 – 13:30 | Q&A and Panel Discussion |
*Sponsored by Eli Lilly
Programme
Tuesday 7 July 12:30 – 13:30 hrs.
| 12:30 – 12:35 | Welcome & Introduction |
| 12:35 – 12:50 | The case for life course vaccination to support healthy ageing By Dr. Stefania Maggi |
| 12:50 – 13:05 | Vaccination as a tool to support non-communicable disease management in older adults By Dr. Jean-Pierre Michel |
| 13:05 – 13:20 | Prevention, resilience and the economic case for adult vaccination By David Sinclair |
| 13:20 – 13:30 | Panel Discussion and Audience Q&A |
*Sponsored by Pfizer
Programme
Wednesday 8 July 12:30 – 13:30 hrs.
The publishing industry has long been obsessed with the “youth market,” often overlooking the world’s most consistent, tech-fluent, and dedicated readers: the 50+ demographic. But as global life expectancy rises, we must move beyond viewing older adults as a niche demographic and start designing for a 100-year life.
In this plenary session, Michael Tamblyn (CEO, Rakuten Kobo) and Sander Knol (Founder, Xander Uitgevers) challenge the industry to stop treating aging as a decline to be managed and start treating it as a design imperative.
Drawing on insights from a new Global Coalition on Aging (GCOA) and Rakuten Kobo report, the analysis moves past the tired debate of digital versus print books to explore how ebooks, audiobooks and ereaders can act as an accessibility bridge, removing the friction that often forces older readers to stop reading. By applying the “curb-cut effect”—the principle that designing for the most accessible use case creates a better experience for everyone— to reading, we can build an ecosystem where the book remains a central pillar of lifelong learning.
Join us for a candid look at the practical, messy work of creating the experiences and services that support cognitive health through lifelong literacy, ensuring that the stories we love remain accessible at every stage of life.
*Sponsored by Rakuten Kobo